To evaluate mortality trends and sociodemographic variations in kidney cancer-related mortality in the U.S. from 1999 to 2023, highlighting the significance of these variations for public health.
Key Findings:
Total kidney cancer-related deaths increased from 10,862 in 1999 to 14,488 in 2023, a 33.38% rise, indicating a growing public health concern.
AAMR declined from 6.15 per 100,000 in 1999 to 5.16 per 100,000 in 2023, with an AAPC of -0.76, suggesting improvements in treatment efficacy.
Distinct mortality trends observed: initial increase (1999-2001), decline (2001-2015), steeper reduction (2015-2019), and a non-significant downward trend (2019-2023), warranting further investigation.
Interpretation:
Despite an increase in total deaths, the age-adjusted mortality rate for kidney malignancies has significantly declined, indicating improvements in management and treatment strategies that need to be further explored.
Limitations:
Study relies on retrospective data, which may not capture all relevant clinical factors, potentially skewing results.
Potential underreporting or misclassification of kidney cancer on death certificates may affect the accuracy of mortality statistics.
Conclusion:
The study highlights the need for targeted interventions to address disparities in kidney cancer mortality, despite overall improvements in age-adjusted mortality rates, emphasizing the importance of equitable healthcare access.
